1077 related articles for article (PubMed ID: 30392156)
1. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
3. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
5. Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).
Novais JS; Rosandiski AC; de Carvalho CM; de Saules Silva LS; Dos S Velasco de Souza LC; Santana MV; Martins NRC; Castro HC; Ferreira VF; Gonzaga DTG; de Resende GO; de C da Silva F
Curr Top Med Chem; 2020; 20(2):121-131. PubMed ID: 31820692
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
7. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
Foroumadi A; Firoozpour L; Emami S; Mansouri S; Ebrahimabadi AH; Asadipour A; Amini M; Saeid-Adeli N; Shafiee A
Arch Pharm Res; 2007 Feb; 30(2):138-45. PubMed ID: 17366732
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H
Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Moshafi MH; Ashraf-Askari R
Farmaco; 2003 Oct; 58(10):1023-8. PubMed ID: 14505733
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives.
Sharma PC; Kumar R; Chaudhary M; Sharma A; Rajak H
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):1-10. PubMed ID: 21981002
[TBL] [Abstract][Full Text] [Related]
13. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of new fluoroquinolones containing a cis- or trans-cyclohexane moiety.
Qi QR; Pan J; Guo XQ; Weng LL; Liang YF
Bioorg Med Chem Lett; 2012 Dec; 22(24):7688-92. PubMed ID: 23102889
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
